Measurement of Anti-dsDNA by Both CLIFT & ELISA
NCT03303508 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 100
Last updated 2017-10-06
Summary
detection of anti-ds DNA in patients with rheumatic diseases by two methodes : immunofluorescence \& ELISA
Conditions
- Antiphospholipid Syndrome
Interventions
- DIAGNOSTIC_TEST
-
anti-ds DNA
venous blood samples
Sponsors & Collaborators
-
Assiut University
lead OTHER
Study Design
- Allocation
- NA
- Purpose
- DIAGNOSTIC
- Masking
- NONE
- Model
- SINGLE_GROUP
Eligibility
- Min Age
- 20 Years
- Max Age
- 70 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2018-09-01
- Primary Completion
- 2019-09-01
- Completion
- 2019-10-01
More Related Trials
-
Cardiac and Laboratory Findings in Patients With Systemic Lupus Erythematosus
NCT03179046 ·Status: COMPLETED
-
Antiphospholipid Antibodies in Patients of Antiphospholipid Syndrome (APS) With Systemic Lupus Erythematosus (SLE).
NCT04963881 ·Status: COMPLETED
-
Value of Uric Acid as Early Predictor of Lupus Nephritis
NCT05402735 ·Status: UNKNOWN
-
Association of Serum Interleukin-33 Levels With Clinical Manifestations in Systemic Lupus Erythematosus
NCT07149402 ·Status: NOT_YET_RECRUITING
-
Study of AC0058TA in Patients With Systemic Lupus Erythematosus (SLE)
NCT03878303 ·Status: UNKNOWN ·Phase: PHASE1
-
Epigenetics in Lupus Nephritis
NCT04648059 ·Status: UNKNOWN
-
Duke Autoimmunity in Pregnancy Registry
NCT00513591 ·Status: COMPLETED
-
Efficacy and Safety of Telitacicept in Early SLE
NCT05899907 ·Status: UNKNOWN ·Phase: PHASE4
-
RLIP76 in Human Serum in Adults With Rheumatologic Diseases
NCT00861159 ·Status: WITHDRAWN
-
Anti-Carbamylated Protein Antibodies in Psoriatic Arthritis
NCT04173039 ·Status: COMPLETED ·Phase: NA
-
The Efficacy and Safety of Telitacicept and Belimumab in Active Lupus Nephritis in the Real World: a Prospective Cohort Study
NCT05588830 ·Status: UNKNOWN
-
AntiDFS70 Lupus Nephritis
NCT06119763 ·Status: RECRUITING
-
Two Anti-CD20 Regimens for Fibrillary Glomerulonephritis
NCT06680349 ·Status: COMPLETED ·Phase: PHASE4
-
Exploratory Study of DHA in Systemic Lupus Erythematosus Patients
NCT03396393 ·Status: UNKNOWN ·Phase: PHASE2
-
Platelet and Red Blood Cell Volume Indices as Inflammatory Biomarkers in Ankylosing Spondylitis
NCT05997108 ·Status: UNKNOWN
-
Anti-CD20 Antibodies for Treatment of SLE-PAH
NCT05828147 ·Status: RECRUITING ·Phase: PHASE4
-
Effect of Injectable Anticoagulants on Research for a Circulating Lupus-type Anticoagulant
NCT05416190 ·Status: COMPLETED ·Phase: NA
-
A Study of DS-7011a in Patients With Systemic Lupus Erythematosus
NCT05638802 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Predictors of Remission and Renal Outcomes in Lupus Nephritis in Assuit University Hospitals.
NCT06228222 ·Status: NOT_YET_RECRUITING
-
Serum Ceramides Level in Systemic Lupus Erythematosus (SLE) Patients as a Novel Marker for Renal Impairment
NCT04256577 ·Status: UNKNOWN
-
Glycosylation Analysis of Lupus Anti-DNA Antibodies (GALA)
NCT05394922 ·Status: RECRUITING
-
Ultrasound-Based Detection Of Subclinical Arthritis Among Patients With Systemic Lupus
NCT05844917 ·Status: UNKNOWN ·Phase: NA
-
Highly Sensitive Serum Cardiac Troponin T and Cardiovascular Events in Patients With Systemic Lupus Erythematosus
NCT04580108 ·Status: COMPLETED
-
Anti-ficolin-2 Autoantibodies in Lupus Nephritis
NCT03063281 ·Status: COMPLETED
-
Effect of Simvastatin on Endothelial Function in Premenopausal Women With Systemic Lupus Erythematosus (0733-271)(TERMINATED)
NCT00739050 ·Status: TERMINATED ·Phase: PHASE4